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Background: Non-invasive screening investigations are rarely used for assessing the activation and progression of
the hypothalamic-pituitary gonadal axis through puberty. This study aimed to establish a normal range for urinary
gonadotrophins in children progressing through puberty.
Methods: Urine samples were collected from 161 healthy school children (76 boys, 85 girls) aged 4–19 yrs. Height
and weight were converted to standard deviation score. Pubertal status, classified by Tanner staging, was
determined by self-assessment. Urinary gonadotrophins were measured by chemiluminescent microparticle
immunoassay. Results were grouped according to pubertal status (pre-pubertal or pubertal).
Results: Of the 161 children, 50 were pre-pubertal (28 boys; 22 girls) and 111 were pubertal (48 boys; 63 girls).
Overall, urinary gonadotrophins concentrations increased with pubertal maturation. All pre-pubertal children had a
low urinary LH:Creatinine ratio. LH:Creatinine ratios were significantly higher in pubertal compared to pre-pubertal
boys (p< 0.001). In girls, FSH:Creatinine ratios were significantly higher in the pubertal group (p= 0.006). However,
LH:FSH ratios were a more consistent discriminant between pre-pubertal and pubertal states in both sexes
(Boys 0.45 pubertal vs 0.1 pre-pubertal; girls 0.23 pubertal vs 0.06 pre-pubertal).
Conclusion: Urinary gonadotrophins analyses could be used as non-invasive integrated measurement of pubertal
status which reflects clinical/physical status.
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At present there are no practical non-invasive screening
investigations to assess the activation and progression of
the hypothalamic-pituitary-gonadal (HPG) axis. Routine
investigations rely on the measurement of serum gonado-
trophins before and after stimulation of gonadotrophic
secretion by GnRH agonists and analysis of various differ-
ent plasma steroids. These tests are expensive, invasive
and often require a visit to the hospital. In addition, they
are not suited for situations where there is a need for serial
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reproduction in any medium, provided the orAnalysis of urinary gonadotrophins in children was first
reported almost 50 years ago [1,2] when highly labour-
intensive methods, requiring numerous pre-treatment pro-
cedures and 24 hr urine collections were necessary. Subse-
quently, the development of more sensitive and specific
automated immunoassays for gonadotrophins has led to a
movement away from urine to serum as the sample of
choice. However, measurement of urinary gonadotrophins
may be of benefit in particular situations such as longitu-
dinal studies [3,4], neonates [5] and pubertal assessment
[6-10]. The aims of this study were, initially, to determine
whether measurement of urinary gonadotrophins could
differentiate between physically pre and post-pubertal chil-
dren and, secondly, to establish and validate normal urinary
gonadotrophin ranges for healthy pre and post-pubertal
children.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.














































Data reported as median (10th and 90th centiles). Height and BMI SDS score
are based on the British 1990 growth reference data [11].
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Study description
A total of 161 healthy children, 76 boys and 85 girls, aged
between 4 and 19 years were recruited from schools in dif-
ferent areas of Glasgow, UK, as part of a study examining
bone health over a 1 year period (2005–6). The study was
approved by the local research ethics committee and each
child and their parents gave informed assent and consent
respectively. Height and weight were recorded at enrol-
ment and converted into standard deviation score (SDS)
using 1990 British children standards [11]. Pubertal status
was determined by children and/or parents using self-
assessment charts and classified according to Tanner
staging as pre-pubertal (Tanner stage 1); early pubertal
(Tanner stage 2–3); late pubertal (Tanner stage 4–5). A
single non-timed urine specimen was collected at enrol-
ment and stored at −20°C for future analyses.
Methodology
Urinary LH and FSH were measured using a chemilumin-
escent microparticle immunoassay (CMIA) from Abbott
on the Architect ci8200 (Abbott Laboratories Diagnostics,
IL, USA). The lower limit of detection for FSH and LH
was 0.1 IU/L and inter and intra-assay precision (CV) for
both LH and FSH were less than 5% at levels of 0.2 and
2.3 IU/L for LH and 0.6 and 4.7 IU/L for FSH. Analytical
sensitivity of the assays was 0.07 IU/L and 0.05 IU/L for
LH and FSH respectively. Urinary creatinine was measured
using the modified Jaffe method with a lower limit quanti-
tation of 0.35 mmol/L. Intra and inter-assay CVs were
2.7% and 3.5% respectively (5.8 and 12.5 mmol/L). Samples
with a creatinine <1.0 mmol/L were regarded as too dilute
for analysis. FSH and LH results were corrected for cre-
atinine to take into account urine concentration.
Statistical analysis
All data were expressed as median (10th and 90th centiles)
and were analysed using SPSSv10.0 (SPSS Inc., Chicago,
IL, USA). Statistical analyses were performed with the
nonparametric Mann–Whitney U test for between-group
comparisons for continuous variables. A p value of less
than 0.05 was considered statistically significant.
Results
General characteristics
The demographics of the cohort according to pubertal
staging are shown in Table 1. Due to the small numbers
in the early and late pubertal groups, children were clas-
sified as being pre-pubertal (Tanner stage I) or pubertal
(Tanner stages II-V). Of the 161 children, 50 were pre-
pubertal (28 boys) with median ages of 7.8 yrs (10th,90th
centiles; 6.2, 11.6) and 8.4 yrs (5.5, 12.6.) in girls, respect-
ively. Of the remaining 111 pubertal children (48 boys),
the median age for boys was 15.0 yrs (12.2, 17.4) andgreater than that for girls (median, 13.6 yrs; 10.7, 17.0).
The median height and BMI SDS data as shown in
Table 1, illustrate that our cohort is representative of a
general childhood population. Median height SDS was
similar in both pre-pubertal boys and girls (boys −0.1 vs
girls −0.3), however the range was wider for boys (−1.2,
1.3 than girls (−1.5, 0.8). In pubertal children, median
height SDS was higher in boys than girls (boys 0.3 (−0.9,
1.2) vs girls −0.1 (−0.9, 1.4). Likewise, median BMI SDS
were similar in pre-pubertal children (boys 0.4 (−1.1, 1.9)
vs girls 0.2 (−1.8, 1.4), with pubertal boys having a
slightly higher median BMI than girls (boys 0.6 (−0.8,
1.5) vs girls 0.1 (−0.8, 1.6).
Urinary gonadotrophins in relation to pubertal status
Of the original 161 samples, 113 (70%) had measurable LH
and FSH. LH was undetectable (< 0.1 IU/L) in 46 samples
(20 boys; 26 girls) with only 2 samples (girls) having un-
detectable FSH (<0.1 IU/L). None of the samples were
regarded too dilute for analysis (creatinine <1.0 mmol/L).
Overall, the median levels of urinary gonadotrophins
increased with pubertal maturation. All pre-pubertal chil-
dren had very low LH:Cr ratio with little spread (median
LH:Cr; boys 0.01 (centiles 0.0, 0.10), girls 0.03 (0.01, 0.85)
(Figure 1a). A significant difference between pre-pubertal
and pubertal LH:Cr ratio was observed in boys with those
in puberty having higher LH concentrations (median LH:
Cr; pre-pubertal 0.01 (0.0, 0.10), pubertal 0.09 (0.02, 0.24)
p< 0.001; Figure 1a). A similar pattern was seen in girls
but the difference was not significant (median LH:Cr; pre-
pubertal 0.03 (0.01, 0.85), pubertal 0.11 (0.11, 0.52)
p< 0.16; Figure 1a). Urinary FSH:Cr ratios showed a simi-
lar pattern with ratios being higher in children undergoing
puberty (Figure 1b). The FSH:Cr ratio was higher in puber-
tal than pre-pubertal girls (median FSH:Cr; pre-pubertal
0.19 (0.10, 0.65) vs pubertal 0.45 (0.14, 1.19); p=0.006


























































Figure 1 a-c - Urinary gonadotrophins grouped according to
pubertal status. a) Median LH:Creatinine, b) FSH:Creatinine and c)
LH:FSH ratios grouped according to pubertal status. The box and
whisker plots represent the median (heavy line), interquartile (box)
and range (whiskers).
McNeilly et al. International Journal of Pediatric Endocrinology 2012, 2012:10 Page 3 of 4
http://www.ijpeonline.com/content/2012/1/10in FSH:Cr ratio between the pre-pubertal and pubertal boys
(p=0.079). Urinary LH:FSH ratio clearly differentiated
between physically pre-pubertal and pubertal children
(Figure 1c). The LH:FSH ratio was higher in the pubertal
than in pre-pubertal group in both sexes, reaching signifi-
cance in boys (median LH:FSH pre-pubertal 0.1 (0.05, 0.37)
vs pubertal 0.45 (0.14, 1.00); p=0.001) but not girls
(median LH:FSH pre-pubertal 0.06 (0.02, 0.61) vs pubertal
0.23 (0.05, 0.53); p=0.067).
Discussion
This study was designed to determine whether measure-
ment of urinary gonadotrophins could distinguish between
physically pre-pubertal and pubertal healthy children. Our
data demonstrated that urinary gonadotrophins could
clearly differentiate between pre-pubertal and pubertal sta-
tus with ratio of LH:FSH proving to be a better discrimin-
ator than either LH or FSH:creatinine.
Importantly, our results are similar to those previously
published in peri-pubertal children despite using non-
extracted, random urines samples and performing the ana-
lyses on a routine automated immunoassay [3,6,8,9]. A
previous report by Kujper et al. investigating neonatal
gonadotrophins showed a strong correlation between urin-
ary and serum FSH and LH measurements using the same
Abbott Architect methods used in our study, confirming
the suitability of this assay for urinary analysis [5].
Urinary LH excretion showed marked difference between
pre-pubertal and pubertal children with pre-pubertal
children having consistently low LH concentrations. Of our
cohort, 46 children had undetectable LH (<0.1 IU/L). LH:
Creatinine ratio was significantly higher in pubertal than
pre-pubertal boys but not girls, despite median LH:Creatin-
ine levels being similar (Figure 1a). The lack of significance
between pre-pubertal and pubertal girls is likely due to the
episodic gonadotrophin excretion pattern that is unique to
early and mid-puberty [9]. Due to the random nature of
the urine collection we may have missed these peaks in
some children. Ideally first-void morning urine samples
would have provided a better reflector of hormonal excre-
tion over the preceding night.
In contrast to LH, urinary FSH excretion was more vari-
able in all groups with no significant difference in excretion
between pre-pubertal and pubertal boys. Both pre-pubertal
and pubertal girls had higher FSH excretion than their male
counterparts, with FSH:Creatinine differing significantly
between pre-pubertal and pubertal girls. These results are
consistent with previous studies which reported in girls that
FSH excretion rose with significant fluctuations with the
onset of puberty with levels remaining greater than LH
until peri-menarche [3,8,9].
In our study, the LH:FSH ratio proved the best dis-
criminator between physically pre-pubertal and pubertal
children with pubertal children having higher ratios than
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or FSH:Creatinine alone is likely due to the consistently
low pre-pubertal urinary LH excretion in both genders. A
possible reason why the difference between pre-pubertal
and pubertal LH:FSH ratio in girls just failed to reach sig-
nificance is the wider range of FSH:Creatinine ratios in the
girls compared to the boys.
It is important to note that some pre-pubertal children
had biochemistry suggestive of hypothalamic-pituitary-
gonadal activation confirming previous observations that
hormonal changes associated with puberty precede exter-
nal physical clinical signs of puberty [6,9,12].
Conclusions
Despite not being routinely utilised as a screening investi-
gation for HPG activation, this study has demonstrated
that urinary gonadotrophin analysis can be used as a non-
invasive integrated measurement of pubertal status which
reflects clinical/physical status. Furthermore, using urine
samples rather than plasma overcomes the issues of sam-
ple insufficiency which is a particular problem in neonates.
Future potential applications for urinary gonadodotrophin
analysis include monitoring efficacy of treatment in preco-
cious puberty and longitudinal studies of pubertal develop-
ment. However further studies are required to determine
the clinical usefulness in these patient cohorts.
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